Black Bryont Pharmaceuticals

Provision of pharmaceuticals and medical services in India.

About Black Bryont Pharmaceuticals

Black Bryont Pharmaceuticals is a Healthcare company. Provision of pharmaceuticals and medical services in India. Its Indian entity Blackbryont Pharmaceuticals Private Limited reported revenue of β‚Ή1.57 Cr. Black Bryont Pharmaceuticals offers products and services including Branded Generics and Medicine Distribution Services. Its focus areas include Pharmaceuticals, Drug Manufacturing, Generic Drugs and Medical Services.

Company details

Quality and affordable pharmaceuticals are provided by Black Bryont Pharmaceuticals to enrich lives, focusing on branded generics for specialties like orthopedics, gynecology, and pediatrics. The company is recognized for its social responsibility in easing sufferings through affordable options and partnerships in healthcare. Achievements include serving over 1 lakh customers with expert pharmacies and more than 10 years of managerial expertise, while emphasizing fast delivery and reliable medicine supply. Operations are based in Kochi, India, with a commitment to collaboration among healthcare professionals.

  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Legal Name Blackbryont Pharmaceuticals Pvt Ltd
  • Date of Incorporation 30 Sep, 2009
  • Jurisdiction Ernakulam, Kerala, India
Key Metrics
  • Indian entity revenue
    ₹1.57 Cr

    FY 2025 · -3% YoY

  • Indian entity net profit
    ₹10,378

    FY 2025 · 0% margin

  • Indian entity EBITDA
    ₹8.8 Lakh

    FY 2025 · 6% margin

Products & Services of Black Bryont Pharmaceuticals

Black Bryont Pharmaceuticals offers a comprehensive portfolio of products and services, including Branded Generics and Medicine Distribution Services.

Branded Generics
Pharmaceutical Products

Generic drugs are supplied by Black Bryont Pharmaceuticals for various medical specialties, including orthopedics and pediatrics.

Medicine Distribution Services
Distribution Services

Medicines are distributed by Black Bryont Pharmaceuticals through partnerships and delivery services to healthcare professionals and pharmacies.

Board of directors of Blackbryont Pharmaceuticals Private Limited (Black Bryont Pharmaceuticals)

Blackbryont Pharmaceuticals Private Limited is the primary company behind Black Bryont Pharmaceuticals. The board of Blackbryont Pharmaceuticals Private Limited currently have 7 directors; the longest-serving is Sugunan Mathilakath, appointed in 2009. 9 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Sugunan Mathilakath
DIN 02764773
Director30 Sep 200917 yrsBlackbryont Pharmaceuticals Private Limited
Ravindran Thekkedath
DIN 00910194
Director30 Sep 200917 yrsBlackbryont Pharmaceuticals Private Limited
Shibu Kurian
DIN 06515877
Additional Director01 Apr 201313 yrs 6 moBlackbryont Pharmaceuticals Private Limited
Jayagopal Narayanan
DIN 06519625
Managing Director01 Apr 201313 yrs 6 moBlackbryont Pharmaceuticals Private Limited
Sivasankara Menon Biju
DIN 06894040
Additional Director01 Jun 201412 yrs 4 moBlackbryont Pharmaceuticals Private Limited
Sivadas Gopi
DIN 08021511
Director13 Dec 20178 yrs 10 moBlackbryont Pharmaceuticals Private Limited
Manoj Valiya Parakkatt
DIN 08021518
Director13 Dec 20178 yrs 10 moBlackbryont Pharmaceuticals Private Limited

Financials of Black Bryont Pharmaceuticals

Figures of Blackbryont Pharmaceuticals Private Limited, the primary company behind Black Bryont Pharmaceuticals, for FY 2025. Revenue was ₹1.57 Cr (-3% year on year). Net profit was ₹10,378 (0% margin). EBITDA was ₹8.8 Lakh (6% margin). Revenue has grown at a compounded annual rate of +10% over three years and +6% over five years.

  • ₹1.57 CrRevenue · FY 2025 · -3% YoY
  • ₹10,378Net profit · 0% margin
  • ₹8.8 LakhEBITDA · 6% margin
  • ₹26 LakhPaid-up capital
  • +10%Revenue CAGR, 3 years
  • +6%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Blackbryont Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Black Bryont Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Black Bryont Pharmaceuticals

The primary company behind Black Bryont Pharmaceuticals, Blackbryont Pharmaceuticals Private Limited, reported revenue of β‚Ή1.57 Cr for FY 2025, down 3% year on year.

Quality and affordable pharmaceuticals are provided by Black Bryont Pharmaceuticals to enrich lives, focusing on branded generics for specialties like orthopedics, gynecology, and pediatrics. The company is recognized for its social responsibility in easing sufferings through affordable options and partnerships in healthcare. Achievements include serving over 1 lakh customers with expert pharmacies and more than 10 years of managerial expertise, while emphasizing fast delivery and reliable medicine supply. Operations are based in Kochi, India, with a commitment to collaboration among healthcare professionals.

Black Bryont Pharmaceuticals offers Branded Generics and Medicine Distribution Services.

Black Bryont Pharmaceuticals operates through Blackbryont Pharmaceuticals Private Limited.

The legal entities of Black Bryont Pharmaceuticals currently have 7 directors, including Sivasankara Menon Biju, Sugunan Mathilakath, Ravindran Thekkedath and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available